• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; REPLACEMENT HEART-VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION MOSAIC AORTIC BIOPROSTHETIC HEART VALVE; REPLACEMENT HEART-VALVE Back to Search Results
Model Number 30519
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Aortic Valve Stenosis (1717); Heart Failure/Congestive Heart Failure (4446); Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 09/27/2021
Event Type  Injury  
Manufacturer Narrative
Citation: sá mp, et al.Bioprosthetic valve fracture for valve-in-valve transcatheter aortic valve implantation in patients with structural valve degeneration: systematic review with meta-analysis.J card surg.2021 dec;36(12):4722-4731.Doi: 10.1111/jocs.16032.Epub 2021 sep 27.Earliest date of publish used for date of event.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information from a literature article regarding the outcomes of bioprosthetic valve fracture (bvf) in valve-in-valve transcatheter aortic valve implantation (viv-tavi) for patients with structural valve degeneration of bioprosthetic surgical valves.All data was collected from a meta-analysis review of four studies published between 2017 and 2021.Of the 242 patients included in the study population (predominant gender not reported for all studies, overall mean age of 78.5 years), approximately 57 were previously implanted with a medtronic mosaic bioprosthetic aortic valve, while approximately 135 underwent viv-tavi with a medtronic transcatheter valve (corevalve = ~77, evolut r/evolut pro = ~58).No unique device identifier numbers were provided.After pooling the data from all four studies included in the analysis, the authors reported an overall 30-day mortality rate of 2.1%.No statement was made suggesting a causal or contributory relationship between medtronic product and the deaths.The authors noted that a proportion of the study population had pre-existing prosthesis-patient mismatch before viv-tavi due to the implant of a small valve size during surgical aortic valve replacement.All mosaic patients underwent viv-tavi with bvf because of structural valve degeneration.Types of degeneration included: stenosis, regurgitation, and mixed stenosis/regurgitation.Additionally, the authors observed the following adverse effects before viv-tavi: heart failure and low ejection fraction (<(><<)>50%).After viv-tavi with bvf, medtronic transcatheter valves may have been associated with the following adverse events: annular rupture, stroke, paravalvular leak, permanent pacemaker implantation, coronary obstruction, coronary obstruction requiring emergent surgical removal of the transcatheter valve, and prosthesis-patient mismatch.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MOSAIC AORTIC BIOPROSTHETIC HEART VALVE
Type of Device
REPLACEMENT HEART-VALVE
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
EI  
091708734
MDR Report Key13054365
MDR Text Key283244556
Report Number2025587-2021-03808
Device Sequence Number1
Product Code DYE
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P990064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number30519
Device Catalogue Number30519
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age79 YR
-
-